HIGHFDA DRUG

Apotex Ketorolac Tromethamine Ophthalmic Solution Recall 2025: 493,468 Bottles Nationwide

Apotex Corp. is recalling 493,468 bottles of Ketorolac Tromethamine Ophthalmic Solution, 0.5%, Rx Only, sterile, distributed nationwide in the United States. The recall cites lack of assurance of sterility due to improper bottle sealing. Consumers and healthcare providers should stop using the product immediately and contact Apotex Corp. or their healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 5, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 5, 2025
Hazard Level
HIGH
Brands
Apotex, Ketorolac Tromethamine
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Apotex, Ketorolac Tromethamine
Product type
Ophthalmic Solution
Model numbers
VA0444, VA4608, TZ7016
UPC codes
60505-1003, 60505-1003-1, 60505-1003-2, 6050510031, 3605051003
Sizes
5 mL
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 5, 2025

  2. Reported by FDA DRUG

    October 8, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Apotex Corp. or your healthcare provider for guidance. Notification method: Letter

About This Product

Ketorolac Tromethamine Ophthalmic Solution is a sterile eye drop used to treat eye pain and inflammation. The product is sold as a prescription medicine and distributed nationwide.

Why This Is Dangerous

A lack of sterility can allow microbial contamination, potentially causing eye infections or other complications in patients.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Patients with affected bottles may be exposed to contaminated solution. The risk is primarily eye infection which could require medical treatment.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 60505-1003-1 on the product packaging.
  2. Check batch numbers VA0444, VA4608, TZ7016.
  3. Confirm expiry: VA0444/VA4608 expire 01/2026; TZ7016 expire 12/2025.
  4. Look for UPCs on bottles and cartons: Bottles 360505100316; Bottle UPC variant (01)0(03)60505100316.

Where to find product info

Review the FDA recall page for D-0677-2025 and Apotex recall notice for batch and disposal instructions.

What timeline to expect

No specific refund or replacement timeline is provided in the recall notice. Follow official guidance for disposal or replacement; expect updates from

If the manufacturer is unresponsive

  • Contact Apotex via the recall notice.
  • Consult your pharmacy or healthcare provider for guidance.
  • If needed, file a consumer complaint with the FDA.

How to prevent similar issues

  • Buy medications only from reputable pharmacies and verify packaging integrity before use.
  • Check NDC and batch numbers when acquiring prescription eye drops.
  • Inspect bottles for signs of leakage or damaged seals before use.

Documentation advice

Keep the recall letter, product packaging, batch numbers, and purchase receipts. Document all communications with the manufacturer and healthcare providers.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL. NDC 60505-1003-1. Manufactured by Apotex Inc., Richmond Hill, Ontario, Canada. Manufactured for Apotex Corp., Weston, FL 33326. Batch numbers: VA0444, VA4608, TZ7016. Expiry: VA0444/VA4608 01/2026; TZ7016 12/2025. UPC: Bottles 360505100316; Bottles UPC on bottle: (01)0(03)60505100316. Quantity: 493,468 bottles. Distribution: Nationwide in the United States. Sold as Rx Only.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Batch VA0444 VA4608 TZ7016
  • Distributed nationwide in the U.S.

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
VA0444
VA4608
TZ7016
UPC Codes
60505-1003
60505-1003-1
60505-1003-2
+2 more
Affected States
ALL
Report Date
October 8, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more